Filing Details
- Accession Number:
- 0000899243-22-026486
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-21 16:48:41
- Reporting Period:
- 2022-07-19
- Accepted Time:
- 2022-07-21 16:48:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-19 | 10,427 | $187.53 | 46,604 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-07-19 | 7,338 | $155.57 | 53,942 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-19 | 963 | $286.72 | 52,979 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-19 | 4,561 | $287.83 | 48,418 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-19 | 5,737 | $288.67 | 42,681 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-19 | 6,604 | $289.48 | 36,077 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-07-19 | 10,427 | $0.00 | 10,427 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-07-19 | 7,338 | $0.00 | 7,338 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,911 | 2029-02-05 | No | 4 | M | Direct | |
| 0 | 2028-02-05 | No | 4 | M | Direct |
Footnotes
- Includes 100 shares previously purchased under the issuer's Employee Stock Purchase Plan.
- Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
- Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $286.72 (range $286.07 to $287.01).
- Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.11 to $288.10).
- Open market sales reported on this line occurred at a weighted average price of $288.67 (range $288.11 to $289.09).
- Open market sales reported on this line occurred at a weighted average price of $289.48 (range $289.11 to $290.06).
- The option vests in 16 quarterly installments from 2/6/2019.
- Fully vested.
Billionaire Hedge Funds
